Skip to content
Screener

Biogen BIIB Total costs & expenses

Total costs & expenses at other companies

TG Therapeutics logo
TG TherapeuticsTGTX
$218.66M+106%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$270.12M+16.3%
Regenxbio logo
RegenxbioRGNX
$78.76M-6.9%

Other financials

Income statement

See full
Revenue$2.7B+3.4%
Gross profit$2.0B-4.0%
Operating income$610.7M
Net income$97.5M-84.6%
EPS (diluted)$0.66-84.8%

Balance sheet

See full
Cash & equivalents$1.3B-53.4%
Total debt$7.6B+14.6%
Total equity$18.8B+6.9%
Total assets$32.1B+13.3%

Cash flow

See full
Operating cash flow$448.9M+179%
CapEx$40.9M+53.8%
Free cash flow$408.0M+204%

Valuation

See full
Market cap$30.53B+61.0%
Enterprise value$36.8B+61.4%
P/E34.6×+22.2×
P/S+1.1×

Profitability

See full
Gross margin74%-1.4pp
Operating margin22.9%
Net margin8.8%-6.5pp
FCF margin26.9%+7.1pp

Returns & leverage

See full
Return on equity4.8%-4.3pp
Debt / equity0.4×0.0×
Current ratio1.9×-0.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: Biogen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 6:36 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000875045-26-000075
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
(Gain) loss on fair value remeasurement of contingent consideration2.513.223.022.8
Restructuring charges165.4(0.7)173.334.6
Other (income) expense, net18.548.738.2117.1
Total cost and expense2,603.61,901.54,703.74,021.3
Income before income tax (benefit) expense132.4744.0510.11,055.2
Income tax (benefit) expense34.9109.293.1179.9
Net income attributable to Biogen Inc.$97.5$634.8$417.0$875.3
Net income per share:

Item 1. Financial Statements (unaudited)

FAQ

What is Biogen's total costs & expenses?
Biogen (BIIB) reported total costs & expenses of $2.6B in Q2 2026.
How has Biogen's total costs & expenses changed year-over-year?
Biogen's total costs & expenses increased by 36.9% year-over-year, from $1.9B to $2.6B.
What is the long-term trend for Biogen's total costs & expenses?
Over 4 years (2021 to 2025), Biogen's total costs & expenses has grown at a 0.6% compound annual growth rate (CAGR), from $8.14B to $8.33B.
What does total costs & expenses mean?
This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue and maintain business operations during a specific period. It encompasses cost of goods sold, research and development investments, selling and administrative overhead, and other charges such as restructuring or impairment costs. Monitoring this figure is essential for evaluating the company's overall cost structure and operational efficiency relative to its top-line performance.

Ask your AI about Biogen's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude